ICU Medical General and Administrative Expenses 2011-2026 | ICUI

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses ICU Medical

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
625 M	639 M	607 M	608 M	303 M	284 M	277 M	328 M	304 M	89.4 M	83.2 M	88.9 M	90.4 M	84.6 M	85.3 M	76.6 M	68.2 M	53.6 M	45.5 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
639 M	45.5 M	249 M

Quarterly General and Administrative Expenses ICU Medical

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1	2010-Q3	2010-Q2	2010-Q1	2009-Q3	2009-Q2	2009-Q1
155 M	153 M	159 M	157 M	-	163 M	160 M	158 M	-	149 M	151 M	153 M	-	153 M	159 M	153 M	-	74.8 M	73.9 M	72.4 M	-	70.9 M	67.2 M	140 M	-	65.9 M	67.8 M	72.6 M	-	76.6 M	81.8 M	85 M	-	76.8 M	85.1 M	64.9 M	-	22.4 M	22.5 M	22 M	-	20.2 M	20.3 M	20.2 M	-	21.8 M	24.3 M	22.5 M	-	22.4 M	23.2 M	22.9 M	-	20.2 M	22.8 M	20.9 M	-	20.4 M	19.7 M	22.9 M	18.3 M	19.4 M	19.7 M	16.8 M	16.5 M	15.1 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
163 M	15.1 M	71 M

General and Administrative Expenses of other stocks in the Medical instruments industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	23.2 K	-	-	$ 810 M	USA
The Cooper Companies COO	1.63 B	$ 62.34	3.31 %	$ 12.4 B	USA
Luminex Corporation LMNX	140 M	-	-	$ 1.75 B	USA
Glaukos Corporation GKOS	332 M	$ 122.13	7.47 %	$ 6.98 B	USA
Akers Biosciences, Inc. AKER	3.73 M	-	-9.52 %	$ 20.6 M	USA
Alcon ALC	251 M	$ 66.36	3.33 %	$ 40.4 B	Schweiz
Intuitive Surgical ISRG	2.38 B	$ 418.57	2.77 %	$ 149 B	USA
iRhythm Technologies IRTC	493 M	$ 107.48	2.79 %	$ 3.44 B	USA
Repro Med Systems KRMD	23.4 M	$ 4.13	5.36 %	$ 191 M	USA
Antares Pharma, Inc. ATRS	62.8 M	-	-	$ 955 M	USA
Cantel Medical Corp. CMD	198 M	-	-1.18 %	$ 3.4 B	USA
CRH Medical Corporation CRHM	8.44 M	-	-	$ 282 M	USA
LeMaitre Vascular LMAT	42 M	$ 93.66	2.2 %	$ 2.12 B	USA
Hill-Rom Holdings, Inc. HRC	941 M	-	-0.05 %	$ 10.3 B	USA
Masimo Corporation MASI	744 M	$ 178.8	0.01 %	$ 9.53 B	USA
Microbot Medical MBOT	8.46 M	$ 1.98	0.51 %	$ 90.7 M	Israel
Ekso Bionics Holdings EKSO	9.99 M	-	-	$ 28.6 M	USA
Milestone Scientific MLSS	11.6 M	$ 0.43	9.72 %	$ 35.3 M	USA
Varian Medical Systems, Inc. VAR	671 M	-	-0.02 %	$ 16.3 B	USA
electroCore ECOR	38.2 M	$ 9.79	-0.71 %	$ 83 K	USA
Envista Holdings Corporation NVST	1.16 B	$ 22.68	1.25 %	$ 3.81 B	USA
Haemonetics Corporation HAE	442 M	$ 69.5	5.49 %	$ 3.28 B	USA
Isoray ISR	30.2 M	-	0.03 %	$ 108 M	USA
STERIS plc STE	1.41 B	$ 212.75	1.17 %	$ 20.9 B	USA
STAAR Surgical Company STAA	85.8 M	$ 29.81	5.47 %	$ 1.48 B	USA
InfuSystem Holdings INFU	57 M	$ 9.04	0.11 %	$ 187 M	USA
Teleflex Incorporated TFX	720 M	$ 131.83	2.54 %	$ 5.88 B	USA
Merit Medical Systems MMSI	455 M	$ 62.93	3.76 %	$ 3.72 B	USA
Utah Medical Products UTMD	7.88 M	$ 68.5	4.53 %	$ 222 M	USA
West Pharmaceutical Services WST	394 M	$ 315.79	-0.16 %	$ 22.8 B	USA
DENTSPLY SIRONA XRAY	1.44 B	$ 9.93	2.96 %	$ 1.98 B	USA
Pulse Biosciences PLSE	32 M	$ 27.7	10.82 %	$ 1.87 B	USA
Retractable Technologies RVP	12.8 M	$ 0.65	-1.1 %	$ 19.5 M	USA
Pro-Dex PDEX	4.84 M	$ 67.5	3.58 %	$ 222 M	USA
Predictive Oncology POAI	25.9 M	-	-	$ 31.1 M	USA
BioLife Solutions BLFS	45.5 M	$ 27.12	-0.5 %	$ 1.3 B	USA
Stereotaxis STXS	17.8 M	$ 1.88	1.9 %	$ 171 M	USA
Baxter International BAX	2.89 B	$ 19.15	3.21 %	$ 9.82 B	USA
ResMed RMD	739 M	$ 192.08	3.01 %	$ 28.1 B	USA
AtriCure ATRC	311 M	$ 27.16	3.65 %	$ 1.3 B	USA
Harvard Bioscience HBIO	17.7 M	$ 6.33	-2.65 %	$ 281 M	USA
NeuroMetrix NURO	6.33 M	-	5.05 %	$ 9.02 M	USA
AngioDynamics ANGO	42.1 M	$ 12.07	7.77 %	$ 493 M	USA
Becton, Dickinson and Company BDX	5.28 B	$ 148.71	2.13 %	$ 42.8 B	USA
Nephros NEPH	9 M	$ 3.6	-1.1 %	$ 38.2 M	USA
OraSure Technologies OSUR	47.7 M	$ 4.17	5.44 %	$ 306 M	USA
Repligen Corporation RGEN	291 M	$ 127.22	4.51 %	$ 7.15 M	USA